Contesting patents on COVID-19 vaccines in the EU: the no profit on pandemic campaign

This article presents and analyses the campaign behind the European Citizens’ Initiative (ECI) ‘No Profit on Pandemic’ which challenged patents for COVID-19 vaccines. Albeit unsuccessful, we argue that the campaign offers a unique opportunity to study the transnationalisation of European contention during the ‘emergency critical juncture’ of the pandemic. We situate the campaign within (1) the broader Europeanisation of health governance and (2) the wider ‘Access to Medicines’ movement to point to the political obstacles and discursive opportunities for anti-patent mobilisation over the period. We conclude that, despite the discursive opportunities offered, the campaign failed to break through the political push-back and the industry opposition. The article, thus, contributes to the literature on health activism, in general, and progressive social movements during the pandemic, in particular, and hopes to shed some light on the global politics of public health.

Authors

Institutions

Publication Details

Journal
Journal of European Public Policy
Published
2024-10-23
DOI
https://doi.org/10.1080/13501763.2024.2418330
Citations
2
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
2.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contesting patents on COVID-19 vaccines in the EU: the no profit on pandemic campaign

Donatella della Porta, Stella Christou
2 citations
Journal of European Public Policy
Pharmaceutical Economics and Policy
2.26
article

Contesting patents on COVID-19 vaccines in the EU: the no profit on pandemic campaign

Donatella della Porta, Stella Christou
article en
2 citations

Abstract

This article presents and analyses the campaign behind the European Citizens’ Initiative (ECI) ‘No Profit on Pandemic’ which challenged patents for COVID-19 vaccines. Albeit unsuccessful, we argue that the campaign offers a unique opportunity to study the transnationalisation of European contention during the ‘emergency critical juncture’ of the pandemic. We situate the campaign within (1) the broader Europeanisation of health governance and (2) the wider ‘Access to Medicines’ movement to point to the political obstacles and discursive opportunities for anti-patent mobilisation over the period. We conclude that, despite the discursive opportunities offered, the campaign failed to break through the political push-back and the industry opposition. The article, thus, contributes to the literature on health activism, in general, and progressive social movements during the pandemic, in particular, and hopes to shed some light on the global politics of public health.

Journal of European Public PolicyVol. 32(8)
Scuola Normale Superiore (IT)
Good health and well-being
Openalex Percentile: Top 8%
Pharmaceutical Economics and Policy
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.